Top 20 of Mycosis Fungoides

Article title # Publications/# Citations

Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.

1980: PABunn; RCGallo; AFGazdar; JDMinna; BJPoiesz; FWRuscetti;

835

T-cell lines established from human T-lymphocytic neoplasias by direct response to T-cell growth factor.

1980: RCGallo; JWMier; BJPoiesz; FWRuscetti; AMWoods;

50

Human lymphoblastoid lines from lymph node and spleen.

1968: VDefendi; JALevy; MVirolainen;

47

Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC).

2007: ISCL/EORTC; MGBernengo; GBurg; RDummer; MDuvic; TEstrach; PHeald; YKim; ... RKnobler; SLamberg; LLaroche; EOlsen; NPimpinelli; MPittelkow; ARanki; WSterry; FTrautinger; EVonderheid; SWhittaker; RWillemze; GWood; HZackheim;

44

Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflamed skin: modulation by recombinant gamma interferon and tumor necrosis factor.

1989: CEGriffiths; BJNickoloff; JJVoorhees;

39

Cutaneous T-cell lymphomas: the Sézary syndrome, mycosis fungoides, and related disorders.

1975: AAhmed; REdelson; IGreen; CKirkpatrick; MLutzner; PSchein;

38

Impaired delayed hypersensitivity in patients with lepromatous leprosy.

1966: JBBlock; JNSheagren; JRTrautman; DSWaldorf;

34

IN-VITRO STUDIES OF LYMPHOCYTES FROM PATIENTS WITH SARCOIDOSIS AND LYMPHOPROLIFERATIVE DISEASES.

1964: FHBach; KHirschhorn; RRSCHREIBMAN; LESiltzbach;

34

Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression.

2003: RTHoppe; YHKim; HLLiu; SMraz-Gernhard; AVarghese;

33

Constitutive activation of a slowly migrating isoform of Stat3 in mycosis fungoides: tyrphostin AG490 inhibits Stat3 activation and growth of mycosis fungoides tumor cell lines.

1997: PDobson; CGeisler; KKaltoft; TMustelin; MNielsen; MNordahl; NOdum; CRopke; ASvejgaard;

32

Monoclonal antibody (UCHL1) that recognises normal and neoplastic T cells in routinely fixed tissues.

1986: PCBeverley; PGIsaacson; AJNorton; ADRamsay; SHSmith;

29

Phenotypic characterization of cutaneous T-cell lymphoma. Use of monoclonal antibodies to compare with other malignant T cells.

1981: PABunn; BFHaynes; RSMetzgar; JDMinna;

29

Structure-function relationships for the IL 2-receptor system. IV. Analysis of the sequence and ligand-binding properties of soluble Tac protein.

1987: RMKutny; RJRobb;

28

T-cell receptor gene rearrangements as clinical markers of human T-cell lymphomas.

1985: VBertness; PABunn; GHollis; BJohnson; IKirsch;

24

Inhibition of constitutively activated Stat3 correlates with altered Bcl-2/Bax expression and induction of apoptosis in mycosis fungoides tumor cells.

1999: KWEriksen; CGeisler; CGKaestel; KKaltoft; MNielsen; NOdum; CRopke; TStokkedal; AWoetmann;

23

Skin effector memory T cells do not recirculate and provide immune protection in alemtuzumab-treated CTCL patients.

2012: NAdams; JBCarter; KSChaney; RAClark; CSCutler; AADorosario; DCFisher; TSKupper; ... NRLeBoeuf; CSchlapbach; MCTawa; JETeague; RWatanabe;

23

Clonal rearrangements of T-cell receptor genes in mycosis fungoides and dermatopathic lymphadenopathy.

1985: MLCleary; EHu; CMoulds; JSklar; RWarnke; LMWeiss; GSWood;

22

Cutaneous T cell lymphoma: mycosis fungoides, Sézary syndrome, and other variants.

1980: RLEdelson;

22

Mycosis fungoides: the pathology of extracutaneous involvement.

1974: HRappaport; LBThomas;

22

In vivo activation of STAT3 in cutaneous T-cell lymphoma. Evidence for an antiapoptotic function of STAT3.

2004: CBrender; OJClemmensen; KWEriksen; CGKaestel; PLovato; ONielsen; MHNissen; NØdum; ... CRopke; SSkov; VHSommer; MWasik; AWoetmann;

21